A Modular Phase 1/2 Study with CT7439 in Participants with Solid Malignancies
- Conditions
- Solid Malignancies
- Interventions
- Drug: CT7439 Capsules (0.5 mg, 1mg, 3mg)
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Carrick Therapeutics Limited
- Target Recruit Count
- 50
- Registration Number
- NCT06600789
- Locations
- 🇬🇧
Research site 06, Sutton, United Kingdom
🇺🇸Research site 03, Dallas, Texas, United States
🇺🇸Research site 01, San Antonio, Texas, United States
A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants
- Conditions
- Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer
- Interventions
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Carrick Therapeutics Limited
- Target Recruit Count
- 60
- Registration Number
- NCT05963984
- Locations
- 🇺🇸
Ocala Oncology Center PL DBA Florida Cancer Affiliates, Ocala, Florida, United States
🇺🇸Mfsmc-Hjwci, Baltimore, Maryland, United States
🇺🇸Saint Luke's Cancer Institute, Kansas City, Missouri, United States
A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer
- Conditions
- Breast CancerMetastatic Breast CancerLocally Advanced Breast Cancer
- Interventions
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Carrick Therapeutics Limited
- Target Recruit Count
- 48
- Registration Number
- NCT05963997
- Locations
- 🇺🇸
Site 38 - Northwestern University, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States
🇺🇸Site 42 - Dana-Farber Cancer Institute, EDDC, Boston, Massachusetts, United States
🇺🇸Site 35 - Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio, United States
Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies
- First Posted Date
- 2017-12-06
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- Carrick Therapeutics Limited
- Target Recruit Count
- 124
- Registration Number
- NCT03363893
- Locations
- 🇺🇸
Research Site 34, Boston, Massachusetts, United States
🇺🇸Research Site 38, Chicago, Illinois, United States
🇬🇧Research Site 6, Southampton, United Kingdom